Cargando…
Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. Although promising strides have been made in the field of PCOS over the past decades, the distinct etiologies of this syndrome are not fully elucidated. Prenatal factors, genetic variation, epigen...
Autores principales: | Wang, Kexin, Li, Yanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622806/ https://www.ncbi.nlm.nih.gov/pubmed/37929034 http://dx.doi.org/10.3389/fendo.2023.1191759 |
Ejemplares similares
-
Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019) -
Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome
por: Wang, Siyu, et al.
Publicado: (2022) -
The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023) -
Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
por: Zhang, Qiaoli, et al.
Publicado: (2022) -
Editorial: Epigenetics of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2023)